Literature DB >> 18404237

Predicting detrusor overactivity using a physician-based scoring system.

Maria Vella1, Dudley Robinson, Linda Cardozo, Sushma Srikrishna, Rufus Cartwright.   

Abstract

Women with lower urinary tract symptoms (LUTS) commonly present to primary care. Management is often based on a symptomatic diagnosis alone although LUTS correlate with urodynamic diagnosis in 65% of cases. The aim of this study was to develop a scoring system to discriminate between the symptoms of stress urinary incontinence (SUI) and overactive bladder (OAB). Physicians completed a specially developed questionnaire for all women complaining of LUTS. Women then underwent videocystourethrography. A scoring system based on the likelihood of each symptom for DO was developed using odds ratios and 95% confidence intervals (CI). This scoring system was subsequently used to discriminate those women with OAB from those with SUI. One hundred seventy one women were recruited to the study. This scoring system had a sensitivity of 79%, a specificity of 78% and a positive predictive value of 73% to identify detrusor overactivity (DO) This new OAB scoring system may be used in primary care to help discriminate between USI and DO.

Entities:  

Mesh:

Year:  2008        PMID: 18404237     DOI: 10.1007/s00192-008-0607-x

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  14 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.

Authors:  Werner Schäfer; Paul Abrams; Limin Liao; Anders Mattiasson; Francesco Pesce; Anders Spangberg; Arthur M Sterling; Norman R Zinner; Philip van Kerrebroeck
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

3.  Tolerability and efficacy of duloxetine in a nontrial situation.

Authors:  J R A Duckett; M Vella; G Kavalakuntla; M Basu
Journal:  BJOG       Date:  2007-03-13       Impact factor: 6.531

4.  The bladder is an unreliable witness.

Authors:  J G Blaivas
Journal:  Neurourol Urodyn       Date:  1996       Impact factor: 2.696

Review 5.  The overactive bladder: pharmacologic basis of drug treatment.

Authors:  K E Andersson
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

6.  Race as a predictor of urinary incontinence and pelvic organ prolapse.

Authors:  C A Graham; V T Mallett
Journal:  Am J Obstet Gynecol       Date:  2001-07       Impact factor: 8.661

7.  Neurological signs are common in patients with urodynamically verified "idiopathic" bladder overactivity.

Authors:  Jarl Ahlberg; Christer Edlund; Carsten Wikkelsö; Lars Rosengren; Magnus Fall
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

8.  Overactive bladder symptoms: do we need urodynamics?

Authors:  G Alessandro Digesu; Vik Khullar; Linda Cardozo; Stefano Salvatore
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

9.  Prevalence and burden of overactive bladder in the United States.

Authors:  W F Stewart; J B Van Rooyen; G W Cundiff; P Abrams; A R Herzog; R Corey; T L Hunt; A J Wein
Journal:  World J Urol       Date:  2002-11-15       Impact factor: 4.226

10.  An assessment of urodynamic examination in incontinent women.

Authors:  G J Jarvis; S Hall; S Stamp; D R Millar; A Johnson
Journal:  Br J Obstet Gynaecol       Date:  1980-10
View more
  2 in total

1.  Improving the clinical prediction of detrusor overactivity by utilizing additional symptoms and signs to overactive bladder symptoms alone.

Authors:  Bernard T Haylen; Tin Lok Chiu; Dianne Avery; Jialun Zhou; Matthew Law
Journal:  Int Urogynecol J       Date:  2014-03-25       Impact factor: 2.894

2.  OAB score: a clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study.

Authors:  Leandro Cristian Arribillaga; Marta Ledesma; Ariel Montedoro; Florencia Pisano; Rubén Guillermo Bengió
Journal:  Int Braz J Urol       Date:  2018 Mar-Apr       Impact factor: 1.541

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.